Literature DB >> 14741399

Functional differences between two DCLK splice variants.

Bart M Engels1, Theo G Schouten, Joost van Dullemen, Ilse Gosens, Erno Vreugdenhil.   

Abstract

Recently, we have cloned two splice variants of the doublecortin-like kinase (DCLK) gene, called DCLK-short-A and -B, both of which encode calcium/calmodulin-dependent protein kinase (CaMK)-like proteins with different C-terminal ends. Using in situ hybridization, we have found that both are highly expressed in limbic structures of the brain and that their expression differs in a number of brain areas. DCLK-short-A is relatively more strongly expressed than DCLK-short-B in the subependymal zone. The DCLK-short-B variant shows stronger expression in the cortex, the ventromedial and dorsomedial hypothalamic nuclei, the arcuate nucleus, the zona incerta and the subincertal nucleus. Also, within the hippocampus, the relative distribution of these two splice variants differs. DCLK-short-B expression compared to DCLK-short-A is highest in the CA1 area. The expression of the A variant is highest in the CA3/CA4 area. Additionally, DCLK-short-B is expressed at a higher level than DCLK-short-A in the substantia nigra and the mammillary nucleus. Both DCLK-short-A and -B were located in the cytoplasm, however DCLK-short-B was also found specifically in growth cone like structures and near the nucleus. Both DCLK-short proteins phosphorylate autocamtide and syntide, two highly specific CaMK substrates. Finally, removal of the C-terminal end of DCLK-short leads to a 10-fold increase of kinase activity, indicating that the different C-termini represent auto-inhibitory domains. Our results indicate that DCLK-short-A and -B control different neuronal processes that overlap with those controlled by CaMKs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14741399     DOI: 10.1016/j.molbrainres.2003.10.006

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  12 in total

1.  Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.

Authors:  Naushad Ali; Heba Allam; Randal May; Sripathi M Sureban; Michael S Bronze; Ted Bader; Shahid Umar; Srikant Anant; Courtney W Houchen
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

Review 2.  APSA Awardee Submission: Tumor/cancer stem cell marker doublecortin-like kinase 1 in liver diseases.

Authors:  Charles B Nguyen; Courtney W Houchen; Naushad Ali
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

3.  The microtubule-associated protein doublecortin-like regulates the transport of the glucocorticoid receptor in neuronal progenitor cells.

Authors:  Carlos P Fitzsimons; Suaad Ahmed; Christiaan F W Wittevrongel; Theo G Schouten; Thomas F Dijkmans; Wim J J M Scheenen; Marcel J M Schaaf; E Ronald de Kloet; Erno Vreugdenhil
Journal:  Mol Endocrinol       Date:  2007-11-01

4.  Can subtle changes in gene expression be consistently detected with different microarray platforms?

Authors:  Paola Pedotti; Peter A C 't Hoen; Erno Vreugdenhil; Geert J Schenk; Rolf Ham Vossen; Yavuz Ariyurek; Mattias de Hollander; Rowan Kuiper; Gertjan J B van Ommen; Johan T den Dunnen; Judith M Boer; Renée X de Menezes
Journal:  BMC Genomics       Date:  2008-03-10       Impact factor: 3.969

5.  Analysis of the clinical significance of DCLK1+ colorectal cancer using novel monoclonal antibodies against DCLK1.

Authors:  Tianqi Dai; Yunlong Hu; Fulian Lv; Tatsuhiko Ozawa; Xin Sun; Jingjing Huang; Xiaojian Han; Hiroyuki Kishi; Atsushi Muraguchi; Aishun Jin
Journal:  Onco Targets Ther       Date:  2018-08-21       Impact factor: 4.147

6.  Variants in doublecortin- and calmodulin kinase like 1, a gene up-regulated by BDNF, are associated with memory and general cognitive abilities.

Authors:  Stéphanie Le Hellard; Bjarte Håvik; Thomas Espeseth; Harald Breilid; Roger Løvlie; Michelle Luciano; Alan J Gow; Sarah E Harris; John M Starr; Karin Wibrand; Astri J Lundervold; David J Porteous; Clive R Bramham; Ian J Deary; Ivar Reinvang; Vidar M Steen
Journal:  PLoS One       Date:  2009-10-21       Impact factor: 3.240

7.  Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms.

Authors:  Peter A C 't Hoen; Yavuz Ariyurek; Helene H Thygesen; Erno Vreugdenhil; Rolf H A M Vossen; Renée X de Menezes; Judith M Boer; Gert-Jan B van Ommen; Johan T den Dunnen
Journal:  Nucleic Acids Res       Date:  2008-10-15       Impact factor: 16.971

8.  Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications.

Authors:  Malaney R O'Connell; Shubhashish Sarkar; Gurinder K Luthra; Yoshinaga Okugawa; Yuji Toiyama; Aakash H Gajjar; Suimin Qiu; Ajay Goel; Pomila Singh
Journal:  Sci Rep       Date:  2015-10-08       Impact factor: 4.379

9.  Doublecortin-like kinase enhances dendritic remodelling and negatively regulates synapse maturation.

Authors:  Euikyung Shin; Yutaro Kashiwagi; Toshihiko Kuriu; Hirohide Iwasaki; Teruyuki Tanaka; Hiroyuki Koizumi; Joseph G Gleeson; Shigeo Okabe
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Expression of alternatively spliced variants of the Dclk1 gene is regulated by psychotropic drugs.

Authors:  Magdalena Zygmunt; Dżesika Hoinkis; Jacek Hajto; Marcin Piechota; Bożena Skupień-Rabian; Urszula Jankowska; Sylwia Kędracka-Krok; Jan Rodriguez Parkitna; Michał Korostyński
Journal:  BMC Neurosci       Date:  2018-09-12       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.